Latest "Cellix Biosciences" News Stories

15:32 EDT 14th August 2018 | BioPortfolio

Here are the most relevant search results for "Cellix Biosciences" found in our extensive news archives from over 250 global news sources.

More Information about Cellix Biosciences on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cellix Biosciences for you to read. Along with our medical data and news we also list Cellix Biosciences Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cellix Biosciences Companies for you to search.

Showing "Cellix Biosciences" News Articles 1–25 of 1,300+


Cellix Biosciences Announces Regulatory Pathway Confirmation for CLX-106 in the U.S.

Cellix Biosciences Inc. (“Cellix Bio”), a development-stage pharmaceutical company, today announced confirmation from the U.S. Food and Drug Administration (FDA) that the 505(b)(2) regulatory pathway is appropriate for development of CLX-106 for treatment of relapsing-remitting multiple sclerosis (RRMS). CLX-106 is a novel molecular conjugate designed ...

Logic Biosciences Announces International Award for LBS-101 Program

Logic Biosciences, Inc., a development-stage pharmaceutical company, today announced that its lead product candidate, LBS-101, has been recognized with an Innovation in Oral Care Award from the International Association for Dental Research (IADR). LBS-101 is a long-acting topical formulation of a novel salt of bupivacaine, being developed for oral pain fro...

V ClinBio Acquires 49.98% Stake in Cellix

Will advance Synergix, a transformative pro-drug technology platform

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women for Biosciences (AWfB), launched on May 10, 2018 in Nairobi aims to address some of the challenges faced by women in biosciences. The event was part ...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...

Apricus Biosciences, Inc.: Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros

Company Evaluating Deficiencies and Potential Path Forward SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative me...


RADNOR, PA / ACCESSWIRE / May 23, 2018 / Kaskela Law LLC reminds Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") investors that a class action complaint has been filed...


Solid Biosciences investors should visit us at call to speak to our claim center toll-free at (844) 367-9658.   About the Lawsuit Solid Read more...

Pawar Law Group: Solid Biosciences Inc. Reminder: Important May 29, 2018 Lead Plaintiff Deadline in Class Action - SLDB

NEW YORK, NY / ACCESSWIRE / April 20, 2018 / Pawar Law Group reminds shareholders who purchased shares of Solid Biosciences Inc. (NASDAQ: SLDB): (1) in Solid Biosciences' initial public offering on...

#Cannabisstocks: Sproutly (CSE:SPR) Closes Acquisition of Infusion Biosciences Canada and SSM

VANCOUVER, British Columbia - August 1, 2018 ( Newswire) Sproutly Canada, Inc. (CSE:SPR) (FRA:38G) ("Sproutly" or the "Company") is pleased to announce that it has completed the acquisition of all of the issued and outstanding shares of Infusion Biosciences Canada Inc. ("Infusion Biosciences Canada") and SSM Partners Inc. ("SSM")

#news #biotech Arcus Biosciences eyes $100M IPO

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Arcus Biosciences eyes $100M IPO .Mere months after bagging $107 million in its series C round, Arcus Biosciences is teeing up for a $100 million IPO, which will … Continue reading → Cet article #news #biotech Arcus Biosciences eyes $100M IPO est apparu en premier ...

Solid Biosciences hit hard by study stoppage

Duchenne’s muscular dystrophy (DMD) specialist Solid Biosciences has been told by the US Food and…

Sygnis acquires TGR BioSciences for €10.1mm

Sygnis AG brought in a complementary genomics/proteomics portfolio through the €10.1mm ($12mm) (net of cash) acquisition of...

Eli Lilly closes $1.6bn ARMO BioSciences acquisition

Eli Lilly has completed the acquisition of immuno-oncology company ARMO BioSciences in an all-cash deal valued at nearly $1.6bn. Lilly...Read More... The post Eli Lilly closes $1.6bn ARMO BioSciences acquisition appeared first on Pharmaceutical Technology.

Brii Biosciences options up to four Vir programs in China

Brii Biosciences launched and entered into an option agreement with Vir Biotechnology Inc.

SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Solid Biosciences, Inc. -- SLDB

RADNOR, PA / ACCESSWIRE / March 30, 2018 / The law firm of Kessler Topaz Meltzer & Check, LLP alerts Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") shareholders that ...

Vortex Biosciences announces management changes

Bob Englert has been promoted from chief technology officer to CEO at Vortex Biosciences, replacing Gene Walther who has resi -More- 

Arcus Biosciences files for IPO

Arcus Biosciences Inc. (cancer immunotherapies) filed for its initial public offering.

In The Spotlight: Catalyst Biosciences

Shares of Catalyst Biosciences Inc. (CBIO) are up an impressive 100% year-to-date in sharp contrast to the NASDAQ Biotechnology Index, which is down nearly 2% during the same period.

Evelo Biosciences files for IPO

Evelo Biosciences Inc. (therapeutics for inflammatory diseases and cancer based on the gut-body network) filed for an initial...

Aptose Biosciences (APTO) vs. Arena Pharmaceuticals (ARNA) Head to Head Contrast

Aptose Biosciences and Arena Pharmaceuticals are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations. This is a breakdown of recent ratings and target prices for Aptose Biosciences and Arena Pharmaceuticals, as pr...

BRIEF—Dyve Biosciences launches as dermal delivery technology company

Dyve Biosciences officially launched today as a new face in the biopharmaceutical space in Thousand Oaks,…

Quick Search


News Quicklinks